KMDA
Kamada
NASDAQ: KMDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.14
+0.37% today
Updated 2026-04-30
Market cap
$474.09M
P/E ratio
23.43
P/S ratio
2.63x
EPS (TTM)
$0.35
Dividend yield
3.05%
52W range
$6 – $9
Volume
0.1M
Kamada (KMDA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.57M | $-12.72M | $-13.09M | $10.63M | $940357.00 | $-8.26M | $-3.85M | $-9.92M | $-13.98M | $1.90M | $3.89M | $10.55M | $28.44M | $19.11M | $-9.17M | $28.59M | $4.32M | $47.59M | $27.59M |
| Capital expenditures | $7.62M | $3.73M | $5.27M | $3.84M | $1.86M | $4.61M | $5.64M | $3.08M | $2.72M | $2.64M | $4.45M | $2.88M | $2.37M | $5.49M | $3.88M | $3.78M | $5.85M | $10.74M | $10.66M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $240677.00 | $307908.00 | $1.67M | $1.78M | $997109.00 | $1.27M | $1.33M | $3.75M | $1.91M | $1.07M | $483000.00 | $948000.00 | $1.16M | $977000.00 | $529000.00 | $1.15M | $1.31M | $874000.00 | $845000.00 |
| Free cash flow | $-20.19M | $-16.45M | $-18.36M | $6.80M | $-922753.00 | $-12.87M | $-9.50M | $-12.99M | $-16.70M | $-744000.00 | $-559000.00 | $7.66M | $26.07M | $13.62M | $-13.04M | $24.80M | $-1.53M | $36.85M | $16.93M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $12.49M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |